Bloodstream Infection
📧 Sign up to get email alerts when something new happens for Bloodstream Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit
This clinical trial update describes a study evaluating rapid molecular diagnostic methods for identifying sepsis pathogens in ICU patients,…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection
This clinical trial update outlines methods for process mapping and data collection to inform a computer simulation model of hospitalised pa…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics [Phase 4]
Phase 4 clinical trial evaluating rapid diagnostic-guided use of ceftazidime-avibactam for bloodstream infections and ventilator-associated …
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems [Phase 2, Phase 3]
Phase 2/3 trial evaluating best available therapy with or without meropenem for bloodstream infections caused by carbapenem-resistant Entero…
-
CLINICAL_TRIALS withdrawal · 2022-05-19Clinical Trial Update: Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection [Phase 3]
Phase 3 trial comparing ceftolozane-tazobactam to meropenem for ESBL/AmpC-producing Enterobacterales bacteremia was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME) [Phase 3]
Phase 3 trial update for OVERCOME evaluating treatment of extensively drug-resistant gram-negative infections; study completed with results …
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Catheter Related - Gram Positive Bloodstream Infections [Phase 2]
Phase 2 clinical trial update on catheter-related Gram-positive bloodstream infections has completed; results posted.
-
CLINICAL_TRIALS research · 2021-01-08Clinical Trial Update: Three-Chamber Bags Retrospective Study in Spain
Retrospective study update on three-chamber bags for parenteral nutrition and bloodstream infection; study completed with results posted in …
-
CLINICAL_TRIALS research · 2018-07-06Clinical Trial Update: Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes
This update describes a multicenter observational study investigating determinants of clinical outcomes in bloodstream infections caused by …
-
CLINICAL_TRIALS trial_result · 2017-11-27Clinical Trial Update: RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp. [Phase 4]
A Phase 4 randomized trial comparing meropenem to piperacillin-tazobactam for definitive treatment of bloodstream infections caused by ceftr…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae [Phase 3]
Phase 3 trial comparing 7-day versus 14-day antibiotic therapy for bloodstream infections caused by Enterobacteriaceae has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Impact of Dedicated Hygienist Staff on the Occurrence of Intensive Care Unit -Aquired Bloodstream Infections
Completed clinical trial assessing whether dedicated hygienist staff reduces ICU-acquired bloodstream infections in the ICU setting.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures [NA]
Mayo Clinic conducted a clinical trial on rapid identification and susceptibility testing of pathogens from blood cultures. The results were…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients [NA]
The clinical trial evaluating antimicrobial catheter securement dressings for preventing central venous catheter-related bloodstream infecti…
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: The Only Blood Culture for Diagnosis of Bacteremia - Comparative Study of Practice [NA]
A completed clinical trial evaluating blood culture approaches for diagnosing bacteremia and comparing practice patterns in bloodstream infe…
-
CLINICAL_TRIALS research · 2015-05-13Clinical Trial Update: Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin [Phase 4]
A Phase 4 pharmacokinetics/pharmacodynamics study of vancomycin is described, sponsored by Zhejiang University, examining its PK/PD in blood…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Topical Emollient Therapy [NA]
A completed clinical trial evaluating topical emollient therapy for bloodstream infection, as reported by Aga Khan University.
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
This completed multicenter observational trial evaluated how specific antimicrobials and minimum inhibitory concentration values affect outc…
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Ethanol Locks for the Treatment of Central Venous Line Infections [Phase 3]
Phase 3 trial evaluating ethanol lock solution to treat central venous catheter-related bloodstream infections was terminated; results were …
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Colistin and Rifampicin for MDR-Acinetobacter [Phase 3]
Phase 3 trial evaluating colistin plus rifampicin for multidrug-resistant Acinetobacter infections has completed.
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: A Development Plan of in Vitro Diagnostics of Immuno Magnetic Reduction Assay - A Rapid Etection Kit of Enterobacteraceae in Blood or Blood Culture
This clinical trial update outlines a development plan for an in vitro diagnostic Immuno Magnetic Reduction (IMR) assay intended as a rapid …
-
CLINICAL_TRIALS research · 2010-06-28Clinical Trial Update: Surveillance for Nosocomial Infections in Pediatric Cancer Patients
The update describes a clinical trial investigating surveillance for nosocomial infections, bloodstream infection, and invasive aspergillosi…